Below are examples of results from 3 patients who responded to treatment in clinical trials with LIBTAYO. Individual patient responses may vary.
This is an example from the 30% (58 out of 193 patients) of patients who saw tumors shrink (partial response) in 1 clinical trial with LIBTAYO.
Pictured below is an ear tumor from a 57-year-old male patient.
He had CSCC that could not be cured by surgery or radiation.
The patient had a response that lasted almost 21 months, after which the disease worsened.
This is an example from the 30% (58 out of 193 patients) of patients who saw tumors shrink (partial response) in 1 clinical trial with LIBTAYO.
Pictured below is a neck tumor from an 85-year-old male patient. He had CSCC that had spread, or metastasized, to other parts of the body.
This is an example from the 17% (33 out of 193 patients) of patients who saw tumors completely disappear (complete response) in 1 clinical trial with LIBTAYO.
Pictured below are chest lesions from a 66-year-old male patient.
He had CSCC that had spread, or metastasized, to other parts of his body.